GlucoTrack Stock (NASDAQ:GCTK), Trade Ideas

GlucoTrack

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

Stock Market Data - chart illustration

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

BSPK

GCTK

TGEN

GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying

Stock Market

AMST

APDN

ATXI

BNAI

CSSE

New Oriental Education & Technology Group

ENPH

FNCH

HELE

ISUN

LICN

MANH

MRSN

MULN

NIVF

NVTS

ODFL

RBBN

RCON

RILY

SNBR

TROO

TSLA

VAXX

VICR

WIMI

Connexa Sports Technologies Inc. - Common Stock

YYAI

Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Intraday Update

Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results

GlucoTrack Inc

Container Store Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCS#NYSE">TCS</a>) reported quarterly Adjusted&nbsp;losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent. This is a 122.22 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $206.04 million which beat the analyst consensus estimate of $204.30 million by 0.85 percent. This is a 20.67 percent decrease over sales of $259.72 million the same period last year.

Container Store Group Q4 Adjusted EPS $(0.04) Beats $(0.12) Estimate, Sales $206.04M Beat $204.30M Estimate

SFL Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFL#NYSE">SFL</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.27 by 33.33 percent. The company reported quarterly sales of $229.064 million which beat the analyst consensus estimate of $213.600 million by 7.24 percent. This is a 32.20 percent increase over sales of $173.266 million the same period last year.

Earnings Beats

SFL Corp Q1 2024 GAAP EPS $0.36 Beats $0.27 Estimate, Sales $229.064M Beat $213.600M Estimate

Stifel analyst Benjamin Burnett maintains Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) with a Hold and raises the price target from $4.4 to $4.6.

Price Target

Analyst Ratings

ALLO

Stifel Maintains Hold on Allogene Therapeutics, Raises Price Target to $4.6

Needham analyst Kyle Peterson reiterates Dun &amp; Bradstreet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNB#NYSE">DNB</a>) with a Buy and maintains $17 price target.

Reiteration

Needham Reiterates Buy on Dun & Bradstreet Hldgs, Maintains $17 Price Target

Stifel analyst Bert Subin maintains AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) with a Buy and raises the price target from $81 to $86.

Stifel Maintains Buy on AAR, Raises Price Target to $86

Mizuho analyst Wei Fang maintains Tencent Music Enter Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) with a Buy and raises the price target from $15 to $17.

Mizuho Maintains Buy on Tencent Music Enter Gr, Raises Price Target to $17

Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) reported quarterly losses of $(0.32) per share. This is a 36 percent increase over losses of $(0.50) per share from the same period last year. The company reported $1.20 million in sales this quarter. This is a 71.43 percent decrease over sales of $4.20 million the same period last year.

AUMN

Golden Minerals Q1 EPS $(0.32) Up From $(0.50) YoY, Sales $1.20M Down From $4.20M YoY

The Company&#39;s Board of Directors along with the management team do not believe the Company&#39;s current market value is reflective of its intrinsic value and are committed to acting in the best interests of the Company and its stakeholders.

The Container Store Group Says Initiated Formal Review Process To Evaluate Strategic Alternatives; Suspends Financial Guidance

Introducing&nbsp;Second Quarter&nbsp;2024 Expectations; Upgrading Full Year 2024&nbsp;Outlook
Second Quarter
<ul>
<li>Revenue of&nbsp;~$1.05 billion</li>
<li>Operating income margin of ~22%; ~24.5%&nbsp;excluding Separation &amp; divestiture costs</li>
</ul>
Full Year
<ul>
<li>Revenue of&nbsp;~$4.4 billion</li>
<li>Operating income margin of ~21%; ~24%&nbsp;excluding Separation &amp; divestiture costs</li>
<li>Cash from operations of &ge;&nbsp;$1.0 billion</li>
<li>Capital expenditures of&nbsp;~$500 million</li>
</ul>

Guidance

Intl Game Tech Expects FY24 Revenue of ~$4.4B (Prior $4.3B-$4.4B) Vs $4.35B Est

Mizuho analyst Sean Kennedy maintains EPAM Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) with a Buy and lowers the price target from $345 to $258.

EPAM

Mizuho Maintains Buy on EPAM Sys, Lowers Price Target to $258

Biotech

Health Care

General

CLRB

Cellectar Biosciences' Cash and Cash Equivalents, As of March 31, 2024, Was $40M That Is Expected To Provide Cash Runway Into Fourth Quarter Of 2024

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPHM#NASDAQ">RPHM</a>) with a Neutral and maintains $1.5 price target.

RPHM

HC Wainwright & Co. Reiterates Neutral on Reneo Pharmaceuticals, Maintains $1.5 Price Target

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) warehouse employees are reportedly using bots to secure coveted time-off slots, raising fresh concerns about the <a href="https://www.benzinga.com/news/24/02/37198475/mark-zuckerberg-on-the-biggest-question-everyones-thinking-about-will-ai-take-away-jobs">impact of technology on jobs</a>.
What Happened: According to a <a href="https://www.404media.co/amazon-workers-use-bots-to-snatch-fiercely-competitive-time-off/">report</a> by 404 Media, Amazon workers are using bots to automatically claim voluntary time off (VTO) slots.
These VTO slots are separate from Amazon&#8217;s unpaid time off (UPT) and do not deduct from UPT reserves. The VTO slots are highly sought after as they contribute towards accumulating more UPT, unlike UPT which is a finite resource.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
When VTO slots become available, they are typically posted in the evening on an Amazon app used by workers to track their shifts. However, by the time workers receive the notification, the VTO slots are already taken, likely by colleagues using bots.
This issue is not new, with Reddit posts dating back several years. These bots are similar to those used to automatically purchase limited supplies of high-demand items like gaming consoles and sneakers.
<a href="https://pro.benzinga.com/dashboard">Benzinga</a> has reached out to Amazon for a statement but did not immediately receive a response.
Why It Matters: The use of bots by Amazon workers to secure VTO slots raises concerns about the potential misuse of technology to disadvantage others who might not be as well-versed in using bots. This is akin to scalping concert tickets, for example, which has <a href="https://www.benzinga.com/news/22/12/29970289/ticketmaster-slapped-with-lawsuit-alleging-violations-of-antitrust-laws-after-taylor-swift-ticket-sa">landed Ticketmaster in a soup in the past</a>.
This also comes amid concerns about AI taking away jobs. Earlier this month, OpenAI CEO Sam Altman, <a href="https://www.benzinga.com/news/24/05/38725610/chatgpt-creator-sam-altman-feels-its-a-massive-massive-issue-that-we-dont-take-ais-threat-to-jobs-an">expressed concerns</a> about the potential job displacement and broader socioeconomic changes that AI could bring about.
This issue has been a subject of debate for some time, with AI&#8217;s potential to <a href="https://www.benzinga.com/news/24/02/37198475/mark-zuckerberg-on-the-biggest-question-everyones-thinking-about-will-ai-take-away-jobs">disrupt the job market</a> being a major concern for many.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/05/38695318/from-beginner-to-enthusiast-top-5-free-harvard-courses-to-spark-your-ai-journey-with-machine-learnin?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">From Beginner To Enthusiast: Top 5 Free Harvard Courses To Spark Your AI Journey With Machine Learning</a>
Disclaimer:&nbsp;This content was partially produced with&nbsp;the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was&nbsp;reviewed and published by Benzinga editors.
Image created using Dall-E

Tech

AMZN

Amazon Workers Turn To Bots To Snatch Precious Time-Off Slots Before Colleagues: Report

WIIM

Alcon shares are trading higher following mixed Q1 financial results.

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) with a Neutral and lowers the price target from $4 to $3.

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

Mizuho Maintains Neutral on Amylyx Pharma, Lowers Price Target to $3

Syros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.86) by 88.37 percent. This is a 88.24 percent increase over losses of $(0.85) per share from the same period last year.

SYRS

Syros Pharmaceuticals Q1 2024 GAAP EPS $(0.10) Beats $(0.86) Estimate,  Cash (Incl Restricted Cash) $85.64M

The Container Store Receives Notice of Non-Compliance With New York Stock Exchange Trading Share Price Listing Rule

STLA

Stellantis shares are trading higher after Biden announced tariffs on Chinese EVs. It was also reported the company and Leapmotor will begin sales of budget EVs in nine European countries.

Intl Game Tech Expects Q2 Revenue of ~$1.05B Vs $1.09B Est

Sea shares are trading higher following a Q1 revenue beat.

Glucotrack selects cirtec medical as manufacturer for its implantable continuous blood glucose monitor

Glucotrack announces increased sensor longevity for its implantable continuous blood glucose monitor

Glucotrack announces expansion into epidural glucose monitoring solutions

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!



Moving stocks this morning are a settlement agreement, Elon Musk&rsquo;s trip to China, a delisting update and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Inno (NYSEARCA:<a href="https://investorplace.com/stock-quotes/inno-stock-quote/">INNO</a>) stock is rocketing more than 58% alongside heavy pre-market trading.</li>



<li>Koninklijke Philips (NYSE:<a href="https://investorplace.com/stock-quotes/phg-stock-quote/">PHG</a>) shares are soaring over 42% after <a href="https://www.cnbc.com/2024/04/29/philips-shares-rocket-33percent-as-firm-settles-us-respiratory-device-case.html">reaching a recall settlement</a>.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) stock is surging more than 22% without any clear news this morning.</li>



<li>IGC Pharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/igc-stock-quote/">IGC</a>) shares are gaining over 19% with strong early morning trading.</li>



<li>Prime Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/prme-stock-quote/">PRME</a>) stock is rising more than 19% despite a lack of news today.</li>



<li>GraniteShares 2x Long TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslr-stock-quote/">TSLR</a>) shares are increasing over 19% after <a href="https://www.bloomberg.com/news/articles/2024-04-29/tesla-clears-key-china-fsd-hurdle-with-baidu-mapping-deal">Elon Musk left China</a> with backing for Tesla&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) self-driving software.</li>



<li>Direxion Daily TSLA Bull 2X Shares (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsll-stock-quote/">TSLL</a>) stock is also heading more than 17% higher alongside the China news.</li>



<li>T-REX 2X Long Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslt-stock-quote/">TSLT</a>) shares are likewise climbing over 17% with the China visit.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is jumping more than 16% on Monday morning.</li>



<li>GlucoTrack (NASDAQ:<a href="https://investorplace.com/stock-quotes/gctk-stock-quote/">GCTK</a>) shares are up close to 16% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Bakkt (NYSE:<a href="https://investorplace.com/stock-quotes/bkkt-stock-quote/">BKKT</a>) stock is crashing over 92% following a <a href="https://www.nasdaq.com/press-release/bakkt-announces-reverse-stock-split-2024-04-23">reverse stock split on Friday</a>.</li>



<li>Marex (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrx-stock-quote/">MRX</a>) shares are plummeting 60% following its <a href="https://www.marex.com/news/2024/04/marex-group-plc-announces-pricing-of-initial-public-offering/">initial public offering (IPO)</a>.</li>



<li>Clever Leaves (NASDAQ:<a href="https://investorplace.com/stock-quotes/clvr-stock-quote/">CLVR</a>) stock is diving more than 58% on <a href="https://www.nasdaq.com/press-release/clever-leaves-announces-voluntary-delisting-and-sec-deregistration-2024-04-26">voluntary delisting plans</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) shares are taking an over 54% beating on a <a href="https://www.nasdaq.com/press-release/addex-provides-update-on-adx71149-phase-2-epilepsy-study-2024-04-29-0">Phase 2 clinical trial update</a>.</li>



<li>GraniteShares 2x Short TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsdd-stock-quote/">TSDD</a>) stock is tumbling more than 18% with Tesla&rsquo;s recent rally.</li>



<li>iSun (NASDAQ:<a href="https://investorplace.com/stock-quotes/isun-stock-quote/">ISUN</a>) shares are sliding over 17% on Monday morning.</li>



<li>T-Rex 2X Inverse Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslz-stock-quote/">TSLZ</a>) stock is dropping more than 17% alongside Tesla&rsquo;s gains.</li>



<li>Boqii (NYSEMKT:<a href="https://investorplace.com/stock-quotes/bq-stock-quote/">BQ</a>) shares are falling over 16% without any apparent news this morning.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock is decreasing more than 14% after a Friday rally.</li>



<li>Nature Wood (NASDAQ:<a href="https://investorplace.com/stock-quotes/nwgl-stock-quote/">NWGL</a>) shares close out our pre-market stock movers down over 14 with no clear news to report.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-29th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

ADXN

AKAN

BKKT

CLVR

INNO

NUZE

NWGL

PRME

TSDD

TSLL

TSLR

TSLT

TSLZ

XTLB

Press Releases

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION